Shane schaffer cingulate
WebShane J. Schaffer. Age : 48. Public asset : 1,520,297 USD. Linked companies : Cingulate Inc. Summary. Shane J. Schaffer founded Cingulate, Inc., Cingulate Works, Inc. and Cingulate … WebJul 11, 2024 · Cingulate Therapeutics LLC, a Kansas City, Kan., pharmaceutical startup, received a big equity investment and landed a new board member on Wednesday. The company received $7.5 million through an...
Shane schaffer cingulate
Did you know?
WebDec 20, 2024 · Shane Schaffer, Chairman & CEO of Cingulate, Inc. CING , was a guest on Benzinga’s All Access on 12/16/22. Cingulate is a clinical-stage biopharmaceutical company focused on the development... Web20 hours ago · Dr. Schaffer will also provide a company overview and recap recent Cingulate clinical and business updates. The event may be viewed live on Benzinga's YouTube …
WebFeb 8, 2024 · Cingulate Inc. (NASDAQ: CING), is a clinical-stage biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a... WebApr 5, 2024 · Cingulate chairman and CEO Shane Schaffer said: “We’re pleased with the speed in which our first cohort of this Phase III trial was able to be completed, …
WebFeb 8, 2024 · Cingulate Inc. today announced updates to its 2024 clinical program for its lead candidate CTx-1301, an investigational asset for the treatment of Attention Deficit/Hyperactivity Disorder (ADHD). ... and ultimately improving patient outcomes,” said Shane J. Schaffer, Cingulate Chairman and Chief Executive Officer. “These studies allow ... WebWho is Cingulate Headquarters 1901 W 47th Pl, Kansas City, Kansas, 66205, United States Phone Number (913) 942-2300 Website www.cingulate.com Revenue $19.2M Stock …
WebAug 18, 2024 · Shane Schaffer, the CEO of Cingulate Therapeutics, said this weekend’s meeting of the company’s seven-member scientific advisory board will include experts from the United States, Canada and...
WebCingulate said the agreement spans cross-functional services via an omnichannel marketing approach aimed at successfully managing pre-commercial support during its phase 3 trials and to... scar 16s barrel twistWebDec 20, 2024 · Shane Schaffer, Chairman & CEO of Cingulate, Inc. CING, was a guest on Benzinga’s All Access on 12/16/22. Cingulate is a clinical-stage biopharmaceutical … rudy fortniteWebJan 9, 2024 · Shane Schaffer, who earned a pharmacy degree at the University of Kansas, founded Cingulate in New Jersey in 2013 after talking with friends in the pharmaceutical … rudy foxWebMay 19, 2024 · Schaffer relocated Cingulate to Kansas in 2014, a year after its founding in New Jersey. The company's roots are tied to a Fourth of July barbecue, where Schaffer … rudy fournierWeb20 hours ago · KANSAS CITY, Kan., April 14, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed … rudy four seasons press conferenceWebJan 16, 2024 · Cingulate Therapeutics chairman and CEO Shane Schaffer said: “Before Cingulate Therapeutics embarks on the studies necessary to gain FDA approval, we’ve been able to gain valuable insight as to how our assets are expected to perform in-vivo. rudy francisco starbucks poem textWebShane Schaffer . The Cingulate Therapeutics Leadership Team possesses a unique combination of clinical, medical, financial, regulatory and commercial expertise, including: • Extensive pharmaceutical industry experience • 50-years of neuroscience clinical experience • Published over 200 peer-reviewed publications scar 16s bolt